Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254162 · ClinicalTrials.gov registry record · Phase 2
Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers
A Phase 2 study of Oily Skin and Seborrhea, sponsored by Mimetica Pty Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT01254162 is a Phase 2 study of Oily Skin and Seborrhea that has completed, run by Mimetica Pty Limited. The registered enrollment target is 135 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01254162, a Phase 2 study of Oily Skin and Seborrhea, has completed, sponsored by Mimetica Pty Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the potential of topically applied 0.75% (w/w) MTC896 Gel to reduce sebum production on the forehead of healthy male volunteers.
Interventions
- DRUG MTC896 Gel
Study Locations (1)
New Jersey
- TKL Research, Inc - Paramus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01254162
The ClinicalTrials.gov registry entry for NCT01254162 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mimetica Pty Limited, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Oily Skin appearing as the primary indexed condition, and to 1 intervention - of which MTC896 Gel is the first listed.
NCT01254162 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01254162 about?
NCT01254162 is a clinical study titled "Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers". To determine the potential of topically applied 0.75% (w/w) MTC896 Gel to reduce sebum production on the forehead of healthy male volunteers.
What is the current status of trial NCT01254162?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2010-07. Estimated completion is 2011-08.
What conditions does trial NCT01254162 study?
This clinical trial studies the following conditions: Oily Skin, Seborrhea.
What interventions are being tested in trial NCT01254162?
The interventions under investigation include: MTC896 Gel (DRUG).
Who is sponsoring clinical trial NCT01254162?
This trial is sponsored by Mimetica Pty Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01254162 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.